Aeglea BioTherapeutics, Inc. (Aeglea BioTherapeutics)
Aeglea BioTherapeutics: Pharmaceutical Company in United States, North America
Aeglea BioTherapeutics, Inc. (Aeglea BioTherapeutics) is a Pharmaceutical Company located in Waltham, MA United States, North America, and was founded in 2013. Current Assets for Aeglea BioTherapeutics is $341,859,000 and SWFI has 10 periods of historical assets, 11 personal contacts available for CSV Export.
2
Recorded Transactions
$341,859,000
Assets
11
Contacts
8
Official Documents
Aeglea BioTherapeutics Details
| Name: | Aeglea BioTherapeutics |
| Legal Name: | Aeglea BioTherapeutics, Inc. |
| DBA: | Aeglea BioTherapeutics |
| LEI: | 52990017AIJPRH3HQH40 |
| Region: | North America |
| Country: | United States | Established At: | 2013 |
| Type: | Pharmaceutical Company |
Aeglea BioTherapeutics Contact Information
| Address: | 221 Crescent Street Suite 105 Waltham, MA 02453 United States |
| State: | MA |
| City: | Waltham |
| Postal: | 02453 |
| Region: | North America |
| Country: | United States |
| Phone: | 1-512-942-2935 |
| Fax: | 1-512-872-5121 |
Aeglea BioTherapeutics Asset Allocation
| Segment | Percentage | Amount (USD) |
|---|---|---|
| Public Equity | Segment percentages and amounts available on swfi.com | |
| Fixed Income | ||
| Real Estate | ||
| Private Equity | ||
| Private Credit | ||
| Hedge Funds | ||
| Infrastructure | ||
| Cash | ||
| Natural Resources | ||
| Other | ||